Remitting agent for nephrotic syndrome and hepatopathy symptoms

C - Chemistry – Metallurgy – 08 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C08B 37/06 (2006.01) C08B 37/00 (2006.01) A61K 31/725 (1990.01)

Patent

CA 2127934

Abstract A remitting agent for nephrotic syndrome and hepatopathy symptoms which comprises water-soluble polysaccharides having poly-D-galacturonic acid as an effective constituent; pulysaccharides having the following characteristic properties which are extractable from Tanjin with water or an aqueous solvent: A. Sugar content: 60 to 100 %. (1) Sugar composition: 40 to 80 % of uronic acid (composed almost entirely of D-galacturonic acid) and 10 to 30 % of neutral sugars (2) Neutral sugar composition: 0 to 15 % of rhamnose 0 to 15 % of glucose 25 to 55 % of galactose 30 to 60 % of arabinose 0 to 15 % of mannose B. Molecular weight: 150,000 to 300,000; and a process for producing the above-described polysaccharides which comprises allowing an aqueous extract of Tanjin to pass through a porous polymeric resin, followed by purification through gel filtration chromatography.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Remitting agent for nephrotic syndrome and hepatopathy symptoms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remitting agent for nephrotic syndrome and hepatopathy symptoms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remitting agent for nephrotic syndrome and hepatopathy symptoms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2019174

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.